|
Schlusskurs
Taiwan S.E.
14.04.2026
|
% 5 Tage
|
Veränd. 1. Jan.
|
|
419,00 TWD
|
-0,71 %
|
 |
-6,68 %
|
-14,14 %
|
|
25.03. |
Bora Pharmaceuticals Prices Bond Offerings
| | |
11.03. |
Bora Pharmaceuticals Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2025
| | |
03.03. |
Bora Pharmaceuticals to Present at the Life Sciences Investor Forum on March 12th
| | |
23.02. |
GSK, Bora Pharmaceuticals Expand Manufacturing Partnership
| | |
23.02. |
GSK, Bora Pharmaceuticals Extend Five-Year Manufacturing Alliance
| | |
23.02. |
Bora Pharmaceuticals and GSK sign $250M five year global manufacturing contract
| | |
23.02. |
Bora Pharmaceuticals Co., Ltd. and GSK Sign $250 Million Five Year Global Manufacturing Contract
| | |
03.02. |
Bora Pharmaceuticals Unit to Buy CDMO Operational Assets for $18 Million
| | |
22.01. |
Bora Pharmaceuticals Unit Gets US FDA Nod for Dry Eye Syndrome Drug
| | |
09.12. |
Bora Pharmaceuticals and Corealis Pharma Forge Strategic Alliance to Deliver Seamless, End-To-End Oral Solid Dose Development
| | |
09.12. |
Bora Pharmaceuticals and Corealis Pharma Forge Strategic Alliance to Deliver Seamless, End-to-End Oral Solid Dose Development
| | |
13.11. |
Bora Pharmaceuticals Co., LTD. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025
| | |
13.11. |
Bora Pharmaceuticals says Jan-Sept net profit T$2.65 bln
| | |
13.10.25 |
Bora Pharmaceuticals to Issue Level 1 ADRs in US OTC Market
| | |
13.10.25 |
Bora Pharmaceuticals plans to sell up to 12.44 million shares on US market
| | |
19.08.25 |
ProMed Pharma, LLC acquired 28,000 square foot, state-of-the-art pharmaceutical manufacturing facility in Plymouth, Minnesota from Bora Pharmaceuticals Co., LTD..
| | |
08.08.25 |
Bora Pharmaceuticals says Jan-Jun net profit T$2.02 bln
| | |
07.08.25 |
Bora Pharmaceuticals Co., LTD. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025
| | |
06.08.25 |
Bora Pharmaceuticals Co., Ltd. Announces Multi-Year Expansion for Midwest Manufacturing Site, as Upsher-Smith Entity Splitis Finalized
| | |
05.08.25 |
Bora Pharmaceuticals Announces Multi-Year Expansion for Midwest Manufacturing Site, as Upsher-Smith Entity Split is Finalized
| | |
18.07.25 |
Bora Pharmaceuticals Cuts Stock Dividend Rate
| | |
06.06.25 |
Tranche Update on Bora Pharmaceuticals Co., LTD.'s Equity Buyback Plan announced on April 8, 2025.
| | |
23.05.25 |
Bora Pharmaceuticals Co., LTD. Announces Cash Dividend, Payable on July 11, 2025
| | |
23.05.25 |
Tanvex BioPharma, Inc. announced that it expects to receive TWD 400 million in funding from Bora Pharmaceuticals Co., LTD.
| | |
14.05.25 |
Bora Pharmaceuticals Logs NT$1.4 Billion Profit in Q1
| |
Keine Ergebnisse zu dieser Suche Bitte wählen Sie Ihre Ausgabe Alle länderspezifischen Finanzinformationen
MarketScreener is also available in this country: United States.
Switch edition
Bei der aktuellen länderspezifischen Edition bleiben
| 
